Ophthalmology Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

Effect of Anti-inflammatory treatment on intraocular pressure after selective laser trabeculoplasty

3rd International Conference on Eye and Vision
August 21-23, 2017 | Toronto, Canada

Laura Palmero Fernandez

Hospital Clinico San Carlos, Spain

Posters & Accepted Abstracts : Ophthalmol Case Rep


Statement of the Problem: Topical steroids are known to increase intraocular pressure (IOP). The purpose of this study is to analyze the effect of anti-inflammatory drops (i.e. comparing topical corticosteroids versus non-steroidal anti-inflammatory drugs - NSAIDs) on intraocular pressure following Selective Laser Trabeculoplasty (SLT). Methodology & Theoretical Orientation: 37 consecutive patients with open-angle glaucoma were randomly allocated into 2 treatment groups after a SLT procedure: ketorolac 0.5% (Acular®, N = 19) and fluorometholone 0.1% drops (FML®, N =18). IOP was measured 1h, 24h, 1 week, and 1, 3 and 6 months after SLT. Findings: IOP reduction was significant in both groups (mean reduction 5.22 ± 3.55 mmHg in the ketorolac group, and 5.19 ± 3.57 mmHg in the fluorometholone group, p < 0.001). There were no statistically significant differences in IOP between both groups through follow-up, except significantly lower IOP in the ketorolac group at 3 months (18.14 ± 2.49 mmHg) than in the fluorometholone group (20.88 ± 3.24 mmHg, p = 0.009), with no differences at 6-month follow-up (mean IOP in both groups 19.09 ± 3.08 mmHg, and 19.69 ± 2.85 mmHg, respectively, p = 0.575). There were no statistically significant differences in mean IOP in the first 24 hours following the procedure (22.26 ± 4.73 in the ketorolac group and 24.36 ± 5.76 mmHg in the fluorometholone group, p = 0.236). Conclusion & Significance: The anti-inflammatory treatment after SLT does not seem to have a short-term effect on the ocular hypotensive efficacy of selective laser trabeculoplasty, nor on the incidence of hypertensive peaks in the early posttreatment follow-up.


Laura Palmero Fernandez is an Ophthalmologist based in Madrid, Spain. She currently combines her work at King Juan Carlos University Hospital with a private practice. Her subfield of expertise includes cornea and ocular surface diseases, and cataract and refractive surgery. Her research is focused on keratoplasty techniques, keratoconus and challenging cornea cases.

Get the App